Rescue schizophrenia-related phenotypes caused by Setd1a deficiency by histone demethylase inhibitors
This study demonstrates that SETD1A deficiency causes region-specific brain dysfunction linked to schizophrenia and identifies the LSD1 inhibitor TAK-418 as a therapeutic agent capable of rescuing associated synaptic and behavioral phenotypes by restoring H3K4me3 levels.